EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
46 hedge funds and large institutions have $73.3M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.12M | |
| 2 | +$978K | |
| 3 | +$947K | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$455K |
| 5 |
TCA
Taconic Capital Advisors
New York
|
+$455K |
Top Sellers
| 1 | -$6.1M | |
| 2 | -$960K | |
| 3 | -$909K | |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
-$428K |
| 5 |
EAM
Exos Asset Management
New York
|
-$103K |